-
Half of people stop taking popular weight-loss drug within a year, national study finds
13 Sep 2025 22:04 GMT
… class of anti-obesity drugs, glucagon-like peptide-1 … taking the weight-loss drug semaglutide in Denmark … many people discontinue the drug?
High costs
The … companies, including AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, …
-
Anti-Obesity Drugs Market Size Drives at 27.04% CAGR by 2034
11 Sep 2025 13:00 GMT
… & Co
AstraZeneca PLC
Gelesis
Boehringer Ingelheim International GmbH
F. Hoffmann-La … acting drugs
By Distribution Channel
Hospital pharmacies
E-commerce
Retail pharmacies
Drug …
-
GST Regime Poised To Ensure Affordable Life-Saving Drugs & Healthcare, India's Pharma Market To See Robust Growth
11 Sep 2025 08:24 GMT
… only make life-saving drugs and healthcare more … 36 vital life-saving drugs, it significantly reduces patient … the revision, life-saving drugs, health-related products, and … GSK, Amgen, Bayer, and Boehringer Ingelheim will also become cheaper, improving …
-
<![CDATA[The HCPFive: Top News for Healthcare Providers from the Week of 09/07]]>
13 Sep 2025 15:19 GMT
… the US Food and Drug Administration (FDA) removal … requirement for the supplemental New Drug Application (sNDA) for sparsentan … for Drug Evaluation and Research, Office of New Drugs accepted … support from Eli Lilly, Boehringer Ingelheim, and Novo Nordisk.
On …
-
Obesity Medication Treatment Perspectives Among People with Overweight or Obesity
13 Sep 2025 11:05 GMT
… , and BMKD are employees of Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). The authors … new prescription weight loss drugs and prescription drug costs 2023. Available from … -new-prescription-weight-loss-drugs-and-prescription-drug-costs/. Accessed …
-
Research Tip Sheet: AI and Heart Failure Plus Recent Headlines
13 Sep 2025 03:06 GMT
… , such as whether a new drug should be added or a … for Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Eli Lilly, Johnson and …
-
<![CDATA[What to Expect at EADV Congress 2025, With Raj Chovatiya, MD, PhD, and Linda Stein Gold, MD]]>
13 Sep 2025 00:40 GMT
… ability to become a commercialized drug," Chovatiya explained. " … dermatitis. We have some new drugs that are pretty much finishing … , Arcutis, Argenx, ASLAN Pharmaceuticals, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics …
-
Appeals court knocks back Novartis’ IRA challenge one week after rejecting bid by BMS, J&J
13 Sep 2025 00:42 GMT
… to believe the IRA’s drug price-setting provisions are … Entresto was among 10 drugs subject to price negotiations … court's ruling against Boehringer Ingelheim. On the same day, … against Novartis, People For Affordable Drugs (P4AD) counts 14 court …
-
Yuhan R&D chief steps down, leaving gap after Leclaza success
12 Sep 2025 02:58 GMT
… gained experience in anticancer drug development at JW Pharmaceutical … was technology-transferred to Boehringer Ingelheim in March this year … on small molecule drug discovery at Boehringer Ingelheim in 2005, … for these new drugs are already highly competitive …
-
Driving Quality from the Top: Merck Manufacturing Leader’s Pitch to PDA Regulatory Conference Audience
11 Sep 2025 21:10 GMT
… cited the highest number of drug-related warning letters in five … , PhD, chief quality officer at Boehringer Ingelheim; Paul Houri, senior vice-president … . Eglovitch, J. S. FDA’s Drug Quality Report Notes ‘Significant’ Uptick …
About
© 1995-2025